Home
Conditions
Lung Neoplasms

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,219 public trials 1,011 recruiting studies

Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Not Yet Recruiting

Tracking T-Cell Responses to Evaluate Pembrolizumab Effectiveness in Advanced Non-Small Cell Lung Cancer

NCT06951399

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations: Davidoff Comprehensive Cancer Center, Rabin Medical Center Petah Tikva, Israel

View Trial Details

Not Yet Recruiting

A Phase II/III Study of IBB0979 in Combination With Topotecan Versus Topotecan in Relapsed Small Cell Lung Cancer

NCT07076095

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Study on the First-line Treatment of Small Cell Lung Cancer With Adebrelimab and Vunakizumab and Chemotherapy

NCT07069270

Conditions: Adebrelimab, Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Safety Study of 212Pb-Pentixather Radioligand Therapy

NCT05557708

Conditions: Bronchial Neoplasms, Carcinoid Tumor Lung, Carcinoma, Bronchogenic, +10 more
Locations: University of Iowa Health Care Iowa City, Iowa, United States

View Trial Details

Not Yet Recruiting

Tumor Associated Neutrophils as a Biomarker of Chemo-immunotherapy Response in Locally Advanced Non-small Cell Lung Cancer : a Model Based on Neoadjuvant Strategy

NCT06974097

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: CHU de Montpellier - Hôpital Arnaud de Villeneuve Montpellier, Cedex 5, France

View Trial Details

Not Yet Recruiting

PANK-003 Cell Injection Combined With Standard Adjuvant Chemotherapy After Surgery in Patients With Stage IIIA NSCLC

NCT07043907

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Prospective, Single-arm, Phase II Clinical Study of Tislelizumab Combined With Anlotinib and Platinum-based Doublet Perioperative Therapy for Resectable Stage II-IIIB Driver Gene-negative NSCLC

NCT06977828

Conditions: Adjuvant Immunotherapy, Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
Locations: The First Affiliated Hospital of Nanjing Medical University Nanjing, Jiangsu, China

View Trial Details

Not Yet Recruiting

Risk and Prognosis of Brain Metastasis in Non-Small Cell Lung Cancer

NCT07034365

Conditions: Brain Diseases, Brain Metastases From Non-small Cell Lung Cancer (NSCLC), Brain Neoplasms, +15 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Clinical Outcomes of Tislelizumab Combined With Chemotherapy as Induction Therapy in Stage III (cTNM-IIIB/IIIC) NSCLC

NCT06829641

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Clinical Trail of KJ015 in Patients With HER2-Expressing Solid Tumors

NCT07036185

Conditions: Bile Duct Cancer, Bile Duct Diseases, Bile Duct Neoplasms, +36 more
Locations: Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Lung Neoplasms

Lung Neoplasms trial results

Related conditions